– A tailored clinical decision support (CDS) tool increased 30‑day reinitiation of ACE inhibitors or ARBs from 13% to 18% among veterans with chronic kidney disease (CKD).
– Absolute improvement was 5% (number needed to treat ~20) over 30 days; most patients still were not reinitiated within that window.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
